Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Direxion Daily S&P Biotech Bull (LABU)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fund basics

See More
  • Annual Dividend Yield N/A
  • Price/Earnings ttm 21.01
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
41.03 +26.15%
on 04/06/17
52.30 -1.03%
on 04/28/17
+4.12 (+8.65%)
since 03/28/17
3-Month
34.30 +50.90%
on 01/31/17
55.20 -6.23%
on 03/15/17
+14.10 (+37.44%)
since 01/27/17
52-Week
21.94 +135.92%
on 06/27/16
55.88 -7.37%
on 09/23/16
+19.26 (+59.26%)
since 04/28/16

Most Recent Stories

More News
Zacks Podcast Highlights: How Do Leveraged and Inverse ETFs Work?

Do you know how leveraged and inverse ETFs work? Find out in this edition of the Dutram Report, where we discuss that topic, and some of the hottest funds in the leveraged and inverse ETF world right now....

GUSH : 57.68 (-2.02%)
SPXL : 129.76 (-0.67%)
XOP : 34.95 (-0.85%)
LABU : 51.76 (+1.17%)
TMV : 21.28 (-0.61%)
CWEB : 32.25 (-1.07%)
XBI : 71.44 (+0.35%)
7 Best Leveraged ETFs So Far in 2017

Amid bouts of volatility, global stocks hit all-time highs on hopes of reflation trade and a slew of robust global data on export, employment and inflation.

BRZU : 39.53 (+3.67%)
JNUG : 4.50 (+2.97%)
EDC : 77.30 (+0.60%)
SHNY : 11.59 (+3.76%)
HAKK : 45.16 (-3.01%)
YINN : 19.97 (-0.10%)
LABU : 51.76 (+1.17%)
7 Best Leveraged ETFs So Far in 2017

Amid bouts of volatility, global stocks hit all-time highs on hopes of reflation trade and a slew of robust global data on export, employment and inflation.

BRZU : 39.53 (+3.67%)
JNUG : 4.50 (+2.97%)
EDC : 77.30 (+0.60%)
SHNY : 11.59 (+3.76%)
HAKK : 45.16 (-3.01%)
YINN : 19.97 (-0.10%)
LABU : 51.76 (+1.17%)
Leveraged ETFs: How Are They Built and What's Hot Now?

Do you know how leveraged and inverse ETFs work? Find out in this edition of the Dutram Report, where we discuss that topic, and some of the hottest funds in the leveraged and inverse ETF world right now....

GUSH : 57.68 (-2.02%)
LABD : 9.43 (-1.26%)
DRIP : 19.26 (+2.61%)
SPXL : 129.76 (-0.67%)
XOP : 34.95 (-0.85%)
LABU : 51.76 (+1.17%)
TMF : 19.55 (+0.57%)
TMV : 21.28 (-0.61%)
XBI : 71.44 (+0.35%)
CWEB : 32.25 (-1.07%)
Stock Market Roundup Jan. 31: Nasdaq Rebounds Amid Trump Biotech Meeting

Following the trend set yesterday, U.S. stocks closed mostly lower on Tuesday but still managed to record monthly gains. Investors continue to weigh the latest policies from the Trump Administration as...

UAA : 21.49 (-0.83%)
TLYS : 9.56 (+1.70%)
JNJ : 123.47 (-0.22%)
IBB : 297.64 (+0.38%)
NVS : 77.03 (-0.04%)
LABU : 51.76 (+1.17%)
AMGN : 163.32 (+0.37%)
TLRD : 12.33 (-3.90%)
XBI : 71.44 (+0.35%)
YIN : 15.76 (+2.40%)
Biotech Stocks Gain on Latest Trump Drug Price Statements

President Trump continues to double down on his campaign promises, and his latest statements regarding drug prices and regulation have sent biotech stocks higher on Tuesday.

CELG : 124.05 (+0.06%)
JNJ : 123.47 (-0.22%)
MRK : 62.33 (-0.40%)
LLY : 82.06 (+0.90%)
IBB : 297.64 (+0.38%)
NVS : 77.03 (-0.04%)
LABU : 51.76 (+1.17%)
AMGN : 163.32 (+0.37%)
XBI : 71.44 (+0.35%)
10 Leveraged/Inverse ETFs with Over 30% Surge in November

Inside the best performing Leveraged/Inverse ETFs of November.

DUST : 32.25 (-5.84%)
URTY : 127.41 (-3.88%)
TNA : 108.69 (-3.89%)
MIDU : 36.45 (-3.08%)
JDST : 19.93 (-3.95%)
FINU : 64.21 (-3.05%)
DTYS : 17.19 (-0.35%)
LABU : 51.76 (+1.17%)
DPST : 59.27 (-5.40%)
KRU : 77.80 (-0.28%)
10 Leveraged/Inverse ETFs with Over 30% Surge in November

Inside the best performing Leveraged/Inverse ETFs of November.

DUST : 32.25 (-5.84%)
URTY : 127.41 (-3.88%)
TNA : 108.69 (-3.89%)
MIDU : 36.45 (-3.08%)
JDST : 19.93 (-3.95%)
FINU : 64.21 (-3.05%)
DTYS : 17.19 (-0.35%)
LABU : 51.76 (+1.17%)
DPST : 59.27 (-5.40%)
KRU : 77.80 (-0.28%)
Bull Market Here to Stay: 10 ETF Ways to Play

The bull trend in the stocks will likely to continue in the coming months assuming that the Trump rally will stretch and seasonality boom.

UDOW : 112.93 (-0.68%)
GUSH : 57.68 (-2.02%)
TNA : 108.69 (-3.89%)
SOXL : 76.44 (-5.10%)
UXI : 55.08 (-1.18%)
MIDU : 36.45 (-3.08%)
ERX : 28.70 (+0.03%)
FINU : 64.21 (-3.05%)
LABU : 51.76 (+1.17%)
DPST : 59.27 (-5.40%)
Bull Market Here to Stay: 10 ETF Ways to Play

The bull trend in the stocks will likely to continue in the coming months assuming that the Trump rally will stretch and seasonality boom.

UDOW : 112.93 (-0.68%)
GUSH : 57.68 (-2.02%)
TNA : 108.69 (-3.89%)
SOXL : 76.44 (-5.10%)
UXI : 55.08 (-1.18%)
MIDU : 36.45 (-3.08%)
ERX : 28.70 (+0.03%)
FINU : 64.21 (-3.05%)
LABU : 51.76 (+1.17%)
DPST : 59.27 (-5.40%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More

Fund Summary

The Direxion Daily S&P Biotech Bull 3x Shares seek daily investment results, before fees and expenses, of 300% or 300% of the inverse (or opposite) of the performance of the S&P Biotechnology Select Industry Index. There is no guarantee the funds will meet their stated investment objectives.

See More

Support & Resistance

2nd Resistance Point 53.43
1st Resistance Point 52.60
Last Price 51.76
1st Support Level 50.63
2nd Support Level 49.49

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.